Cargando…
Hemorrhage Is a Major Cause of Blood Transfusion in COVID-19 Patients
INTRODUCTION Reports from China and other countries have allowed to quickly understand the clinical and biological features of COVID-19. In contrast, little has been published on the transfusion requirements of COVID-19 patients and the clinical characteristics of transfused patients. PATIENTS AND M...
Autores principales: | Sanz, Cristina, Faundez, Anabel, García Carulla, Anna, Rodriguez Aliberas, Marta, Coromoto, Anny, Pereira, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330354/ http://dx.doi.org/10.1182/blood-2020-138830 |
Ejemplares similares
-
Oxygenation and Inflammatory Markers after Early Covid-19 Convalescent Plasma: A Comparison of Survivors and Non-Survivors
por: Baez Sosa, Valentina, et al.
Publicado: (2021) -
Caring for Patients with Sickle Cell Disease during a Pandemic: Continuing to Provide Automated Red Blood Cell Exchange Transfusions in Difficult Times
por: Godby, Richard Curtis, et al.
Publicado: (2020) -
Phase I and Preliminary Results of a Phase II Study (TERAPLASCoV2) of Convalescent Plasma in Patients with Severe and Life-Threatening Pneumonia Caused By Sars-Cov-2
por: Pérez-Jacobo, Fernando, et al.
Publicado: (2020) -
Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience
por: Browning, Sabrina L., et al.
Publicado: (2020) -
Antibody Response Against Sars-Cov-2 in Convalescent Plasma Donors: Preliminary Results from a Single Center in Midwest Brazil
por: Roberti, Maria do Rosario Ferraz, et al.
Publicado: (2020)